Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,100 | 30 | 97.2% |
| Education | $87.92 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $796.21 | 8 | $0 (2023) |
| Dutch Ophthalmic, USA | $481.17 | 3 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $415.84 | 4 | $0 (2022) |
| Genentech USA, Inc. | $410.11 | 4 | $0 (2024) |
| Alcon Puerto Rico Inc | $356.14 | 4 | $0 (2023) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $321.10 | 3 | $0 (2020) |
| Apellis Pharmaceuticals, Inc. | $240.10 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $97.09 | 1 | $0 (2019) |
| Carl Zeiss Meditec, Inc. | $69.76 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.32 | 3 | Genentech USA, Inc. ($135.22) |
| 2023 | $909.61 | 8 | Dutch Ophthalmic, USA ($481.17) |
| 2022 | $685.24 | 7 | Bausch & Lomb Americas Inc. ($415.84) |
| 2021 | $117.42 | 1 | Regeneron Healthcare Solutions, Inc. ($117.42) |
| 2020 | $102.18 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($102.18) |
| 2019 | $828.68 | 8 | Alcon Puerto Rico Inc ($249.99) |
| 2018 | $189.75 | 2 | Regeneron Healthcare Solutions, Inc. ($105.00) |
| 2017 | $104.32 | 1 | Regeneron Healthcare Solutions, Inc. ($104.32) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Ophthalmology | ||||||
| 04/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $135.22 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $93.22 | General |
| Category: Ophthalmology | ||||||
| 12/01/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $132.49 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/07/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $150.35 | General |
| Category: Ophthalmology | ||||||
| 05/24/2023 | Alcon Puerto Rico Inc | Clareon (Device) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Ophthalmology | ||||||
| 04/25/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $200.49 | General |
| Category: Ophthalmology | ||||||
| 02/06/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/02/2023 | Apellis Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| 01/18/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $130.33 | General |
| Category: Ophthalmology | ||||||
| 12/08/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/13/2022 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $115.65 | General |
| Category: Ophthalmology | ||||||
| 09/08/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/14/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $127.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/16/2022 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $53.48 | General |
| Category: Ophthalmology | ||||||
| 05/11/2022 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $123.53 | General |
| Category: Ophthalmology | ||||||
| 01/05/2022 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $123.18 | General |
| Category: Ophthalmology | ||||||
| 11/05/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $117.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/04/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | STELLARIS PC (Device) | Food and Beverage | In-kind items and services | $102.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/06/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/25/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VITESSE (Device) | Food and Beverage | In-kind items and services | $170.63 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/06/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VITESSE (Device) | Food and Beverage | In-kind items and services | $48.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/31/2019 | Carl Zeiss Meditec, Inc. | — | Food and Beverage | In-kind items and services | $69.76 | General |
| 05/02/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $97.09 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 332 | 707 | $59,184 | $43,010 |
| 2022 | 8 | 351 | 683 | $57,978 | $40,544 |
| 2021 | 10 | 422 | 789 | $62,778 | $45,307 |
| 2020 | 8 | 464 | 846 | $72,983 | $51,843 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 20 | 31 | $15,965 | $12,163 | 76.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 86 | 183 | $16,549 | $11,976 | 72.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 21 | 93 | $10,546 | $7,447 | 70.6% |
| 92134 | Imaging of retina | Office | 2023 | 76 | 151 | $6,136 | $4,505 | 73.4% |
| J3490 | Unclassified drugs | Office | 2023 | 18 | 68 | $3,400 | $2,470 | 72.7% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 75 | 132 | $3,264 | $2,395 | 73.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 19 | 19 | $2,855 | $1,691 | 59.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 17 | 30 | $467.70 | $363.44 | 77.7% |
| 67210 | Destruction of growth of retina using a laser | Office | 2022 | 21 | 31 | $16,144 | $12,093 | 74.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 87 | 164 | $14,869 | $9,652 | 64.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 24 | 89 | $10,202 | $7,244 | 71.0% |
| 92134 | Imaging of retina | Office | 2022 | 82 | 151 | $6,208 | $4,227 | 68.1% |
| J3490 | Unclassified drugs | Office | 2022 | 23 | 74 | $3,700 | $2,805 | 75.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 22 | 22 | $3,357 | $2,117 | 63.1% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2022 | 70 | 120 | $2,999 | $2,091 | 69.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 22 | 32 | $500.07 | $314.56 | 62.9% |
| 67210 | Laser destruction of retinal growth, 1 or more sessions | Office | 2021 | 20 | 26 | $13,634 | $10,659 | 78.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 94 | 172 | $15,668 | $10,336 | 66.0% |
| 67028 | Injection of drug into eye | Office | 2021 | 25 | 101 | $11,674 | $8,692 | 74.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 98 | 172 | $7,148 | $4,822 | 67.5% |
| J3490 | Unclassified drugs | Office | 2021 | 25 | 88 | $4,400 | $3,400 | 77.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 27 | 27 | $4,135 | $3,003 | 72.6% |
| 92201 | Extended examination of eye with drawing of retina | Office | 2021 | 90 | 146 | $3,667 | $2,554 | 69.6% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2021 | 12 | 12 | $1,441 | $1,153 | 80.0% |
| 92250 | Photography of the retina | Office | 2021 | 12 | 12 | $479.64 | $353.96 | 73.8% |
About Dr. Robert Boada, MD
Dr. Robert Boada, MD is a Ophthalmology healthcare provider based in Bayamon, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578527396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Boada, MD has received a total of $3,188 in payments from pharmaceutical and medical device companies, with $250.32 received in 2024. These payments were reported across 31 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($3,100).
As a Medicare-enrolled provider, Boada has provided services to 1,569 Medicare beneficiaries, totaling 3,025 services with total Medicare billing of $180,704. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Bayamon, PR
- Active Since 04/17/2006
- Last Updated 04/05/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578527396
Products in Payments
- EVA, combined machine (Device) $481.17
- EYLEA (Biological) $461.89
- Stellaris (Device) $415.84
- Vabysmo (Drug) $267.71
- NGENUITY (Device) $249.99
- VITESSE (Device) $218.92
- EYLEA AFLIBERCEPT INJECTION (Biological) $209.32
- VABYSMO (Drug) $142.40
- EYLEA HD (Biological) $125.00
- Syfovre (Drug) $115.10
- STELLARIS PC (Device) $102.18
- SHINGRIX (Biological) $97.09
- ReSTOR (Device) $84.75
- Clareon (Device) $21.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bayamon
Ricardo Cumba-Bermudez, M.d, M.D
Ophthalmology — Payments: $7,592
Dr. Hector Villarrubia, M.d, M.D
Ophthalmology — Payments: $2,524
Enrique Rivera Rivera, M.d, M.D
Ophthalmology — Payments: $2,119
Mr. Jose Cumba, Md, MD
Ophthalmology — Payments: $1,939
Dr. Jose Miranda, M.d, M.D
Ophthalmology — Payments: $1,882
Luis Hernandez-Cott, M.d, M.D
Ophthalmology — Payments: $1,594